Join us for this interactive, live symposium where nationally renowned faculty will address:

• The Latest Psychopharmacology Advances: New Medications & New Formulations

SATURDAY OCTOBER 20, 2012

KINGSGATE MARRIOTT CONFERENCE HOTEL AT THE UNIVERSITY

OF CINCINNATI

EARN UP TO 7.5 AMA PRA CATEGORY 1

CREDITS™

www.PsychPharmUpdate.org

SYMPOSIUM DIRECTOR Henry A. Nasrallah, MD PROFESSOR OF PSYCHIATRY AND NEUROSCIENCE UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE

FACULTY

Leslie Citrome, MD, MPH NEW YORK MEDICAL COLLEGE

Henry A. Nasrallah, MD UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE

Rajiv Tandon, MD UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE

Richard H. Weisler, MD UNC CHAPEL HILL, DUKE UNIVERSITY MEDICAL CENTER

ENDORSED BY:

UPDATE

2012 I 11th ANNUALPRESENTS

Dear Colleague,On behalf of the University of Cincinnati and CURRENT PSYCHIATRY, it is my pleasure to invite you to attend our 11th Annual Psychopharmacology Update.

This highly informative educational meeting will offer a full day of clinically relevant psychopharma-cology advances and up to 7.5 CME credits. In our interactive format, nationally renowned faculty will bring you up to date on the latest advances in psychopharmacology by discussing new medications and new formulations.

This well-established, one-day CME symposium offers an outstanding opportunity for education and networking with minimal disruption to your busy schedule. You will get in-depth analysis from our expert faculty and ample time to query them on topics that will help keep your practice ahead of the curve.

I look forward to leading this symposium in Cincinnati at the Marriott Kingsgate Conference Center, and I hope to see you there.

Sincerely,

Henry A. Nasrallah, MD SYMPOSIUM DIRECTOR

Rajiv Tandon, MDProfessor, Department of PsychiatryUniversity of Florida College of MedicineGainesville, FL

Dr. Tandon is professor of Psychiatry at University of Florida and the Chief of Psychiatry in the Program of Mental Health at the State of Florida’s Department of Children and Families. Formerly, he was Professor at the Department of Psychiatry in the University of Michigan Medical Center, Ann Arbor, from 1987–2004. In addition to his medical degree, he has a Master’s degree in Clinical Research Design and Statistical Analysis from the University of Michigan School of Public Health and a diploma in Business Administration from the Harvard University Business School. At the University of Michigan, he developed the Clinical and Research Schizophrenia Program, which was the sixth most published schizophrenia program in the world in the 1990’s. Dr. Tandon has authored more than 250 scientific publications, and given over 600 national and international scientific presentations.

Richard H. Weisler, MDAdjunct Professor of PsychiatryUNC Chapel Hill School of MedicineChapel Hill, NCAdjunct Associate Professor of Psychiatry and Behavioral SciencesDuke University Medical CenterDurham, NC

Dr. Weisler, Adjunct Professor of Psychiatry at UNC Chapel Hill and Adjunct Associate Professor of Psychiatry and Behavorial Sciences at Duke, has been in practice since 1980 in Raleigh, North Carolina, where his group currently follows more than 2,000 patients with a mixture of psychiatric disorders. He is a past recipient of the Outstanding Teaching Award from the UNC Chapel Hill Psychiatry Department. Dr. Weisler is credited with first identifying the usefulness of Lamictal (lamotrigine) in bipolar disorder when, in 1993, he presented a report on his successful treatment on a compassionate use basis of two severely treatment-resistant bipolar patients with the then-unapproved drug. Dr. Weisler is board certified by the American Board of Psychiatry and Neurology. He has been the principal investigator in over 250 clinical trials. Dr. Weisler has authored or co-authored more than 75 journal articles and book chapters on bipolar disorder, attention deficit disorder, depression, PTSD, social phobia, dementia, pharmaco-economics, suicide and generalized anxiety disorders.

UPDATE

ABOUT OUR DIRECTOR AND FACULTY

Henry A. Nasrallah, MD Professor, Department of Psychiatry and Behavioral Neuroscience University of Cincinnati Cincinnati, OH

Dr. Nasrallah is the director of the Schizophrenia Research Program at University of Cincinnati, and his research focuses on the neurobiology and psychopharmacology of schizophrenia and related disorders. He is Editor-In-Chief of two prominent journals (Current Psychiatry and Schizophrenia Research) and is the co-founder of the Schizophrenia International Research Society. He is a fellow of the American College of Neuropsychopharmacology, fellow of the American College of Psychiatrists, distinguished life fellow of the American Psychiatric Association, past president of the Cincinnati Psychiatric Society and the American Academy of Clinical Psychiatrists, current president of the Ohio Psychiatric Physicians Education and Research Foundation, and past president of the University of Cincinnati College of Medicine Faculty Forum.

Leslie Citrome, MD, MPHClinical Professor of Psychiatry & Behavioral SciencesN ew York Medical CollegeValhalla, NY

Dr. Citrome, Clinical Professor of Psychiatry & Behavorial Sciences at New York Medical College, is a principal investigator, co-investigator, and collaborator on a number of ongoing projects centering on psychopharmaceutical approaches to schizophrenia and bipolar disorders, including new and novel medications, treatment–refractory schizophrenia, and the management of aggressive and violent behavior. He also is an active member of the Medication Utilization and Outcomes Research Program that focuses on the practice of psychiatry within the 16 hospitals operated by the New York State Office of Mental Health.

6:45 – 7:45 am Registration and Breakfast

7:45 – 8:00 am Welcome and Introduction HENRY A. NASRALLAH, MD

8:00 – 9:00 am New Antipsychotics: How Are They Different? LESLIE CITROME, MD, MPH

9:00 – 10:00 am New Antidepressants: What’s New About Them?RICHARD WEISLER, MD

10:00 – 10:15 am Break

10:15 – 11:15 am New ADHD Medications: Options for Children and Adults RICHARD WEISLER, MD

11:15 AM – 12:15 pm Heated Psychopharmacology Debate The DSM-5 At-Risk Diagnosis: Should It Exist and Should It Be Treated?HENRY A. NASRALLAH, MD | RAJIV TANDON, MD

12:15 – 1:45 pm Luncheon Symposium

1:45 – 2:00 pm Dessert Break

2:00 – 3:00 pm New Formulations and Delivery Systems for Psychotropics: Beyond the Usual PillLESLIE CITROME, MD, MPH

3:00 – 4:00 pm In the Pipeline: Glutamate Modulators for Depression and PsychosisLESLIE CITROME, MD | RICHARD WEISLER, MD

4:00 – 5:00 pm Stump the Experts Panel Discussion Moderator:HENRY A. NASRALLAH, MDPanelists: LESLIE CITROME, MD, MPH | RICHARD WEISLER, MD | RAJIV TANDON, MD

5:00 – 5:30 pm Review of Key Points and Conclusions

Kingsgate Marriott Conference Hotel 151 Goodman Avenue Cincinnati, OH 45219 TEL: 513-487-3800 FAX: 513-487-3810

The Kingsgate Marriott Conference Hotel at the University of Cincinnati is the premier University of Cincinnati hotel. We have arranged for discount room rates of $119 per night for participants of the Psychopharmacology Update. The cut-off date for the discount rate is September 20, 2012.

To make your reservations, please call 888-720-1299 and be sure to mention the Psychopharmacology Update, or register at www.marriott.com/cvgkg.

ONLINE: www.PsychPharmUpdate.orgBY PHONE: (502) 574-9023 BY FAX: (502) 589-3602 BY E-MAIL: kkirchner@hqtrs.com BY MAIL: Kim Kirchner, Registration Coordinator c/o Quadrant HealthCom Inc. 455 S. Fourth Street, Suite 650 Louisville, KY 40202 Cancellation Policy: 2012 Psychopharmacology Update will offer a full refund, less a $50 administrative fee as follows: requests for refunds must be made in writing, postmarked, emailed or faxed prior to September 20, 2012. After September 20, no refunds will be granted. Substitutions are welcomed in lieu of cancellations. Refunds will not be issued to no-shows.

REGISTRATION FORM (PLEASE PRINT)

FIRST NAME LAST NAME

DEGREE: ❑ MD ❑ DO ❑ NP /PA ❑ PHARMD ❑ RN ❑ PHD❑ RESIDENT ❑ OTHER, PLEASE SPECIFY

AFFILIATION

TYPE OF PRACTICE: ❑ OFFICE ❑ HOSPITAL ❑ OTHER

ADDRESS

CITY/STATE/ZIP

E-MAIL (for registration confirmation and CME certificate)

PHONE FAX

PAYMENT INFORMATION : CREDIT CARD: ❑ AMEX ❑ MC ❑ VISA ❑ CHECK ENCLOSED (MADE PAYABLE TO QUADRANT/PSYCHUPDATE)

CARD NUMBER EXP. DATE

CARDHOLDER SIGNATURE DATE

Register online at www.PsychPharmUpdate.org

ABOUT OUR VENUE

5 WAYS TO REGISTER

REGISTRATION PRICING

Until Aug. 17

Aug. 18 to Sept. 21

After Sept. 21

Physicians $170 $220 $320

OPPA members $145 $195 $320

Psychologists, Social Workers/ Allied Health

$145 $165 $185

Residents/Fellows

$65 $65 $65

AGENDA Subject to change. Check www.psychpharmupdate.org for updates.

ACCREDITATION AND CREDIT DESIGNATION STATEMENTS The University of Cincinnati is accredited by the Accreditation Council of Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Cincinnati designates this live activity for a maximum of 7.5 AMA PRA Category 1 Credits™. Physicians should only claim credits commensurate with their participation in the activity.

This activity is endorsed by Current Psychiatry.

LEARNER ASSURANCE STATEMENT The University of Cincinnati is committed to resolving all conflicts of interest issues that could arise as a result of prospective faculty members’ significant relationships with drug or device manufacturer(s). The University of Cincinnati is committed to retaining only those speakers with financial interests that can be reconciled with the goals and educational integrity of this CME activity.

NURSING CREDIT 7.5 continuing education contact hours for nurses are approved by the Ohio Board of Nursing through the OBN Approver Unit at the University of Cincinnati College of Nursing, Continuing Education Program

(OBN-011-93). Contact hours are valid in most states.

SPECIAL NEEDS NOTICE The University of Cincinnati College of Medicine is committed to providing courses in a location and manner accessible to persons with disabilities. If you require special accommodations due to a disability, please call us at 513-558-5326.

DISCLAIMER STATEMENT The opinions expressed during the activity are those of the faculty and do not necessarily represent the views of the University of Cincinnati. The information is presented for the purpose of advancing the attendees’ professional development.

Join us for this interactive, live symposium

• The Latest Psychpharmacology Advances: New Medications & New Formulations

SATURDAY, OCTOBER 20, 2012CINCINNATI, OHIO

Endorsed by: www.PsychPharmUpdate.org

EARN UP TO 7.5 AMA PRA CATEGORY 1

CREDITS™

Current PsyChiatry

7 Century Drive, Ste 302Parsippany, NJ 07054

UPDATE

2012 I 11th ANNUAL

SYMPOSIUM DIRECTOR Henry A. Nasrallah, MD University of Cincinnati College of Medicine

FACULTY

Leslie Citrome, MD, MPHNew York Medical College

Rajiv Tandon, MDUniversity of Florida

Richard H. Weisler, MDUNC Chapel Hill Duke University College of Medicine

Presented by the University of Cincinnati College of Medicine

Department of Psychiatry.

WHO SHOULD PARTICIPATE? This activity is designed for child and adolescent psychiatrists, general psychiatrists, geriatric psychiatrists, nurse practitioners, physician assistants, nurses, psychologists, social workers, and other mental health professionals interested in treating patients with psychiatric disorders to remission with measurement-based care.

PROGRAM GLOBAL OBJECTIVES At the conclusion of this CME symposium, those in attendance should be able to: • Discuss the emerging new mechanisms

for drug development in schizophrenia outside the dopamine pathways.

• Review the various novel formulations for psychotropic agents and the advan-tages of various delivery samples beyond the traditional oral medications.

• Employ combination therapy for cer-tain psychiatric conditions with multiple symptom domains or comorbidities.

• Apply nonpharmacological interventions in conjunction with pharmacotherapy to enhance patient improvement when medication alone is not enough.

• Discuss numerous DSM-IV disorders that have no FDA-approved medication and how to manage them until drugs become indicated for these disorders.

Last Chance!PRESENTS

Register by August 17Save $150